NCT03426332

Brief Summary

The management of adrenal crisis is often problematic and the time to adequate treatment is frequently delayed.The aim of the study is to evaluate the management of adrenal emergencies requiring parenteral glucocorticoid treatment by a prospective multicenter study in patients with chronic adrenal insufficiency.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 18, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 8, 2018

Completed
Last Updated

February 8, 2018

Status Verified

February 1, 2018

Enrollment Period

2 years

First QC Date

January 18, 2018

Last Update Submit

February 1, 2018

Conditions

Keywords

Adrenal InsufficiencyAdrenal crisisAdrenal emergencyGlucocorticoid injection

Outcome Measures

Primary Outcomes (5)

  • Median time from contacting a medical professional to arrival of professional medical help

    Evaluation of the median time (in minutes) from contacting a medical professional (by the patient) to arrival of professional medical help during an (adrenal) emergency. The time is documented in a questionnaire by the patients themselves (directly after the adrenal emergency). The data of all patients will be stated as median and range.

    6-36 months

  • Median time from showing the emergency card (by a patient) to glucocorticoid-injection by a medical professional

    Evaluation of the median time (in minutes) from showing the emergency card (by a patient) to glucocorticoid-injection by a medical professional. The time is documented in a questionnaire by the patients themselves (directly after the adrenal emergency). The data of all patients will be stated as median and range.

    6-36 months

  • Median time from the beginning of symptoms to glucocorticoid-injection

    Evaluation of the median time (in minutes) from the beginning of symptoms to glucocorticoid-injection during an (adrenal) emergency. The time is documented in a questionnaire by the patients themselves (directly after the adrenal emergency). The data of all patients will be stated as median and range.

    6-36 months

  • Duration of hospitalisation (number of days at a hospital)

    Evaluation of the duration of hospitalisation (number of days at a hospital) due to an adrenal emergency. The number of days is documented by the patients themselves (directly after the adrenal emergency). The data of all patients will be stated as median and range.

    6-36 months

  • Number of patients that received an intramuscular glucocorticoid-injection

    Evaluation of the number of patients that received an intramuscular glucocorticoid-injection (compared to subcutaneous administration) during an adrenal emergency. Documentation by the patients themselves directly after the adrenal emergency.

    6-36 months

Secondary Outcomes (5)

  • Cause of the adrenal emergency

    6-36 months

  • Median time from the beginning of symptoms to oral dose adjustment (glucocorticoids) during an adrenal emergency

    6-36 months

  • Median time from the beginning of symptoms to contacting a medical professional

    6-36 months

  • Symptoms of the adrenal emergency

    6-36 months

  • Median amount of additionally oral ingested glucocorticoids during the adrenal emergency

    6-36 months

Interventions

No intervention

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged ≥18 years with a documented chronic adrenal insufficiency under established corticosteroid replacement therapy.

You may qualify if:

  • Age ≥18 years
  • Documented chronic adrenal insufficiency
  • Established corticosteroid replacement therapy
  • Written informed consent

You may not qualify if:

  • \- Age \<18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, Beuschlein F, Willenberg HS, Quinkler M, Allolio B. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2015 Feb;100(2):407-16. doi: 10.1210/jc.2014-3191. Epub 2014 Nov 24.

    PMID: 25419882BACKGROUND
  • Hahner S, Hemmelmann N, Quinkler M, Beuschlein F, Spinnler C, Allolio B. Timelines in the management of adrenal crisis - targets, limits and reality. Clin Endocrinol (Oxf). 2015 Apr;82(4):497-502. doi: 10.1111/cen.12609. Epub 2014 Nov 6.

    PMID: 25200922BACKGROUND
  • Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol. 2015 Mar;172(3):R115-24. doi: 10.1530/EJE-14-0824. Epub 2014 Oct 6.

    PMID: 25288693BACKGROUND

MeSH Terms

Conditions

Adrenal Insufficiency

Condition Hierarchy (Ancestors)

Adrenal Gland DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2018

First Posted

February 8, 2018

Study Start

November 1, 2015

Primary Completion

November 1, 2017

Study Completion

November 1, 2017

Last Updated

February 8, 2018

Record last verified: 2018-02